What Is The Price Target For Fate Therapeutics Fate Stock Fate Q4 2025 Earnings Fate Therapeutics Inc. Posts Narrow Eps Beat No Revenue Reported 20260410 1 Bill Ackmans Pershing Square Acquires Microsoft Stake Betting on AI and Cloud Growth Biohaven BHVN Q1 2026 Profit Slips to 088 Misses Analyst Forecasts Fed Minutes Reveal Majority of Officials Anticipate Rate Hikes If Inflation Persists Amid Geopolitical Risks Tech Leads as Markets Hold Flat Energy Slips EU Considers Tariffs and Supply Chain Shifts as China Trade Tensions Intensify Innospec IOSP Among Notable Small Cap Stocks as Company Boosts Dividend and Launches Share Repurchase Microsofts New Trusted Technology Lead Jenny LayFlurrie Navigates Tension Between AI Speed and Responsibility Analyst Highlights Potential in Wipro and Eicher Motors Recovery Signals and Bullish Indicators EU Industry Chief Warns Against Overreliance on Single Country Supply Chains Tesla Stock Forms ThreeWeeksTight Pattern Amid Recovery From Deep Slump SpaceXs Path to Nasdaq Listing Highlights Starlinks Central Role in Growth and Profitability